News | July 06, 2022
StimLabs announces new placental membrane-based product ‘Enverse’
The introduction of Enverse is part of StimLabs' aim to simplify patient care for both physicians and the hospital systems
The introduction of Enverse is part of StimLabs' aim to simplify patient care for both physicians and the hospital systems
The AICVD tool can predict the risk of cardiovascular disease.
People in India are still wary of organ transplants. So, there is an urgent need of increased public awareness.
Medicines, including insulin, to be available in 40 lower-income countries
Transcatheter Mitral valve procedure allows intervention on patients who are unsuitable or high risk for open heart surgery
_256_384.jpg){kind=logo}
Meets the growing need for US-based API solubility and bioavailability enhancement services
Lacosamide Injection is used to treat partial-onset seizures.
The Government of Quebec, through its agent Investissement Quebec, is granting a loan of CAD 25 million
The total covered market size of four brands – Z&D, Pediclory, Pecef & Ezinapi combined is Rs 1800 crores
The settlement and dismissal resolves all claims between the parties
Subscribe To Our Newsletter & Stay Updated
